Showing results (451-460 of 487) with videos related to
Sort By:
Pageof 49
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1997
Characterization of lidocaine-specific T cellsM P Zanni, D Mauri-Hellweg, C Brander, et al.Seminars in Oncology|October 1, 1994
High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directionsA D Elias, L J Ayash, C Wheeler, et al.Cancer|May 15, 1993
Cisplatin, 5-fluorouracil, and etoposide for advanced non-small cell lung cancerT J Lynch, F Kass, L A Kalish, et al.Cancer|February 1, 1983
Survival of patients with localized high-grade soft tissue sarcoma with multimodality therapy. A matched control studyK H Antman, R H Blum, R E Wilson, et al.Cancer Clinical Trials|January 1, 1978
A therapeutic trial of maytansineR H Blum, B K Wittenberg, G P Canellos, et al.Bone Marrow Transplantation|October 11, 2001
A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer: sequential phase I/II studiesA D Elias, P Richardson, D Avigan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1992
Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor responseL J Ayash, J E Wright, O Tretyakov, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1983
Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD)A T Skarin, G P Canellos, D S Rosenthal, et al.Journal of the National Cancer Institute|April 7, 1993
Intensive combined modality therapy for limited-stage small-cell lung cancerA D Elias, L Ayash, E Frei, et al.Chest|April 1, 1993
High-dose combined alkylating agent therapy with autologous stem cell support and chest radiotherapy for limited small-cell lung cancerA D Elias, L Ayash, A T Skarin, et al.Pageof 49